PLOD3 and colorectal carcinoma: Notably, knockdown of PLOD3 markedly hindered the development of CRC tumors, as evidenced by the reduced number and size of tumors in the PLOD3 knockdown group compared to those in the control group, as determined by gross examination (Fig. 5E).